Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. - Wikidata - wikimedia - TriplyDB

Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.

Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.

http://www.wikidata.org/entity/Q34983738

about

Dendrimer advances for the central nervous system delivery of therapeutics Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.Polyamidoamine dendrimer-conjugated triamcinolone acetonide attenuates nerve injury-induced spinal cord microglia activation and mechanical allodynia.Nanoengineering of therapeutics for retinal vascular disease.Degradable polyethylenimine derivate coupled to a bifunctional peptide R13 as a new gene-delivery vector Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina.Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation Targeted nanosystems: Advances in targeted dendrimers for cancer therapy Nanomedicine in cerebral palsy.Microglia activation in a pediatric rabbit model of tuberculous meningitis Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.The complex of PAMAM-OH dendrimer with Angiotensin (1-7) prevented the disuse-induced skeletal muscle atrophy in mice.Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Effect of Terminal Groups of Dendrimers in the Complexation with Antisense Oligonucleotides and Cell Uptake.Nanomaterial applications in multiple sclerosis inflamed brain.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.Promising low-toxicity of viologen-phosphorus dendrimers against embryonic mouse hippocampal cells.Viologen-phosphorus dendrimers exhibit minor toxicity against a murine neuroblastoma cell line.Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.Increase in Dye:Dendrimer Ratio Decreases Cellular Uptake of Neutral Dendrimers in RAW Cells.Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies.Activated Microglia Targeting Dendrimer-Minocycline Conjugate as Therapeutics for Neuroinflammation.Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia.Fluorescent Phosphorus Dendrimer as a Spectral Nanosensor for Macrophage Polarization and Fate Tracking in Spinal Cord Injury.Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.Is an episode of suspected preterm labor that subsequently leads to a term delivery benign?Brain Delivery of Multifunctional Dendrimer Protein Bioconjugates.Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful Nanomedicine The biodistribution of maltotriose modified poly(propylene imine) (PPI) dendrimers conjugated with fluorescein-proofs of crossing blood-brain-barrier

P2860

Q26828423-7C0C7667-D9A4-438C-AB50-3E4970FA2126 Q30528069-9A141857-5C08-45E8-AE63-302C7DCE0FAB Q33610514-2F390473-5C3F-4848-87C8-7BDF044EB669 Q35645705-B7281D95-65E6-4124-9930-35A5DAB1D591 Q35821070-9A14C295-AED0-4C4F-84E7-DD30FCBB252E Q35877208-8C39E5DB-BF0E-4646-B147-1FF391E2E5C4 Q36520379-3E60BF11-DA17-4CE1-B61D-975FDC8E001B Q36566183-09B8D0E7-D101-4486-B1E1-8DF3F8F81A8E Q36679983-D7293F01-C07E-41D2-A51B-20869F9C0D6D Q37281194-CDB751DA-AF18-4D12-B6CB-D0AA6C2ACA0E Q37545421-EF03D981-FCDC-4B3F-923E-69D0436ABC1B Q37687066-12D4741F-5FBA-4F15-82D4-6137FC96EDD9 Q37709770-87F531D3-F6EE-4E38-A3C0-321300178665 Q37731623-00D625EC-CABC-43FD-95A8-B1C973A6D003 Q37737065-3673EDBA-2B5C-4503-8652-9D61C7BCCCDD Q37886750-D5C55517-09CE-46D4-AC67-F2DA459C6343 Q38264255-7CC3F497-1976-42D5-9B4F-4528D326BCC4 Q38330408-E8676A79-38C9-4F47-AE3C-951AAE1C5E9B Q38896543-A0D42DA7-D9D1-435C-8520-956CE4621814 Q38937398-63298E48-0A1B-480B-A98E-BCA828D1FFDE Q39089271-099FBC75-FB73-43AA-83E3-13B5380FC51B Q39119209-8A822E17-AAB0-4F2C-989C-75386263C5EA Q39479822-CC194CFC-C271-48E0-AFEF-80CDB1907619 Q42317454-AE805FBA-B2B0-42DF-9D56-14D5CD246600 Q47429306-9304C51C-1FCC-4097-8B19-843AC56B13C3 Q47447718-3468CF9D-FB34-4B78-859D-685FBC186716 Q48215874-B0AA9312-523B-47B3-87A0-E74216663B9F Q48661111-50387AD2-F695-41E3-96A1-415ABFCAE421 Q49017113-210BB686-1C5C-4632-8B62-CEDA605BD284 Q49243157-043F42C7-E73A-473C-81D3-90A6B44023B5 Q55057822-1F911B41-1C39-4380-B3BC-A1BDFECF5784 Q57556323-B7DA041D-59E3-4ABD-AE37-6B4592575138 Q57777403-CC346185-780D-440D-9C1D-40E05D56BA79

P2860

Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.

http://www.wikidata.org/entity/Q34983738

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@ast

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@en

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@nl

type

label

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@ast

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@en

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@nl

prefLabel

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@ast

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@en

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@nl

P1433

Q34983738-98E5B889-E073-4969-93B7-453D38C6767D

P1476

Q34983738-B9182289-E7FA-49C8-9E6C-F13845FB3524

P2093

Q34983738-2240B605-6A64-4C60-8143-FD7AC38BEA7D

Q34983738-34A0DACB-57BA-4F98-B22B-91F0B92A1513

Q34983738-52557765-4ACC-4BBE-88E9-A9A095E0E9EC

Q34983738-BB5EFC8D-7C4D-4069-A9D3-43C46463B3AD

Q34983738-FCABC274-1AA5-413E-A0EF-A32C2EE785AC

P2860

Q34983738-021BC56A-0442-4336-9E6E-7BB502ACB546

Q34983738-0888CC9F-97B3-4CF3-9FD9-266ED306379B

Q34983738-0A410E34-C550-427F-AD64-627CE3516A05

Q34983738-0A48948D-208A-4179-B101-EBDE584EAAFA

Q34983738-0FB94AD7-29F7-4A46-84F9-082FC9F38832

Q34983738-22053345-B79A-46E3-99D8-D395E6B5A838

Q34983738-31715992-C3FA-4D1B-BF3A-09DE10E35C62

Q34983738-3A8AD8B2-5864-4525-8B48-F37A6F6E80C9

Q34983738-3B9DC6A3-3E10-43CC-85BA-E84442C8849C

Q34983738-3DC0D6A7-BDFF-49D1-B3AC-A8535A372D06

P304

Q34983738-3B5ACB17-5B47-4BA0-9242-A0BE14C0E305

P31

Q34983738-CBBCE273-87FC-44B7-932C-5847F0A282FD

P356

Q34983738-AB806EC2-B1BE-4974-8973-C9405C682F80

P433

Q34983738-6938A910-36A3-4103-805D-FAC69E4B555F

P478

Q34983738-928655B4-B217-4B2C-BF8B-4095617B412B

P50

Q34983738-7032FA16-79A6-479E-9D41-164F63F68A9D

Q34983738-986D352E-44AD-44A9-8549-308EB08DD2FA

Q34983738-FED69431-5D22-436A-9E4D-6A13F223DD6C

P577

Q34983738-5BE0868B-9706-480B-8CC9-5C05F6A02F2C

P5875

Q34983738-A8EB19C6-4D79-4C59-95C2-892876A11107

P698

Q34983738-87EA8151-EA09-4649-A65E-A44C6F9B455F

P921

Q34983738-4C0FFE56-70EB-4ED0-AA13-58354DAC8814

P932

Q34983738-6DCC78D0-0317-4F51-9FB8-69755D22A3FE

P356

P1433

P1476

Intrinsic targeting of inflamm ...... n subarachnoid administration.

@en

P2093

Bindu Balakrishnan

http://www.w3.org/2001/XMLSchema#string

Hui Dai

http://www.w3.org/2001/XMLSchema#string

Manoj K Mishra

http://www.w3.org/2001/XMLSchema#string

Raghavendra S Navath

http://www.w3.org/2001/XMLSchema#string

Rangaramanujam M Kannan

http://www.w3.org/2001/XMLSchema#string

P2860

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord

Migration of perilesional microglia after focal brain injury and modulation by CC chemokine receptor 5: an in situ time-lapse confocal imaging study.

Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.

Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.

Robust uptake of magnetic nanoparticles (MNPs) by central nervous system (CNS) microglia: implications for particle uptake in mixed neural cell populations

Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates.

Blood-brain barrier delivery.

P304

1317-1329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.10.89

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Bharath Raja Guru

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49655566

http://www.w3.org/2001/XMLSchema#string

P698

21128716

http://www.w3.org/2001/XMLSchema#string

P921

P932

3095441

http://www.w3.org/2001/XMLSchema#string